In vivo evaluation model mice for predicting drug brain permeability and intestinal absorption.
The TC-huMDR1TM mouse is a trans-chromosomic (Tc: chromosomal insertion) mouse (B6 strain) that introduces the human MDR1 gene into a mouse that has knocked out the intrinsic mdr1a/1b genes (mMDR1-KOTM) using an "artificial chromosome vector," making it the world's first 'human-type P-gp model mouse' that expresses functional P-glycoprotein (P-gp). Features and Benefits: * Functional human P-gp protein is expressed. * The AUC of TC-huMDR1TM mice and mMDR1-KOTM mice can be used to evaluate human brain permeability and P-gp-mediated drug-drug interactions. * Using TC-huMDR1TM mice and physiological pharmacokinetic (PBPK) modeling, quantitative predictions of human nonlinear absorption mediated by P-gp can be made. * This allows for the selection of compounds with ideal pharmacokinetic profiles in drug discovery, facilitating more appropriate management of P-gp-mediated drug-drug interactions in clinical settings. *For more details, please refer to the PDF materials or feel free to contact us.*
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
P3
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Detailed information
-
Suggestions for the Use of TC-huMDR1 Mice in Drug Discovery Research
catalog(1)
Download All CatalogsCompany information
TransChromosomics Co., Ltd. is a Tottori University-based biotech venture established with the aim of developing drug discovery and drug discovery support tools, leveraging the know-how of chromosome engineering technology acquired by CEO Mitsuo Oshimura during his 30 years of research. Using cutting-edge chromosome engineering technology, the company conducts chromosome modification, iPS/ES cell production, genetically modified mouse and rat production, animal testing, and antibody production, among other activities.